Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$391,436,886
+$353,917,125 QoQ
Shares Held
5,589,560
+656.8% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#13
of 777 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. MRNA ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $391,436,886 | 5,589,560 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,519,761 | 738,578 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,567,295 | 494,013 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,471,294 | 482,865 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,220,546 | 624,159 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,227,574 | 642,948 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $44,617,626 | 1,073,055 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,570,396 | 1,459,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $189,967,699 | 1,599,728 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $108,605,631 | 1,019,197 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $110,140,377 | 1,107,495 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $154,422,474 | 1,495,038 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $145,974,231 | 1,201,434 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $247,640,224 | 1,612,451 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $490,183,518 | 2,729,003 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $761,933,113 | 6,443,409 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $484,600,625 | 3,392,374 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $416,600,646 | 2,418,441 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $617,630,595 | 2,431,808 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $938,323,317 | 2,438,090 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $522,260,673 | 2,222,575 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $306,147,350 | 2,337,895 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $140,482,898 | 1,344,720 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $69,938,992 | 988,537 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $65,292,580 | 1,016,860 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,743,007 | 525,643 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||